|
| 37205234 | Response to Comment: Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines Against COVID-19 Hospitalizations. | Open Forum Infect Dis | 2023 |
| 35580849 | Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States. | Clin Infect Dis | 2023 |
| 36993496 | Protocol and statistical analysis plan for the PREOXI trial of preoxygenation with noninvasive ventilation vs oxygen mask. | medRxiv | 2023 |
| 37255285 | Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022. | Clin Infect Dis | 2023 |
| 35264324 | Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. | BMJ | 2022 |
| 35675695 | Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States. | Clin Infect Dis | 2022 |
| 36695662 | Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022. | Open Forum Infect Dis | 2022 |
| 36580424 | Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged â¿¥65 Years - IVY Network, 18 States, September 8-November 30, 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 36755543 | Using a multicultural and multilingual awareness-raising strategy to enhance enrollment of racially underrepresented minoritized communities - the <i>PassITON</i> trial. | J Clin Transl Sci | 2022 |
| 36220174 | Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study. | BMJ | 2022 |
| 36344144 | Response. | Chest | 2022 |
| 35085218 | Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34932114 | Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021. | J Infect Dis | 2022 |
| 35324878 | Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022. | MMWR Morb Mortal Wkly Rep | 2022 |
| 34901783 | Standardized two-step testing of antibody activity in COVID-19 convalescent plasma. | iScience | 2022 |
| 34403367 | Metabolic preconditioning in CD4+ T cells restores inducible immune tolerance in lupus-prone mice. | JCI Insight | 2021 |
| 33743799 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Trials | 2021 |
| 33521603 | A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity. | iScience | 2021 |
| 33688640 | Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. | Res Sq | 2021 |
| 34734975 | Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. | JAMA | 2021 |
| 31337270 | Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data. | Annu Rev Pharmacol Toxicol | 2020 |
| 31051414 | FcγRIIb on CD11c<sup>+</sup> cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr<sup>-/-</sup> mice. | Atherosclerosis | 2019 |
| 30806246 | How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses. | Crit Rev Immunol | 2018 |
| 28130494 | Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9. | J Immunol | 2017 |
| 28381829 | Fine tuning of immunometabolism for the treatment of rheumatic diseases. | Nat Rev Rheumatol | 2017 |
| 24395554 | Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice. | Ann Rheum Dis | 2015 |
| 25738608 | Diminished reovirus capsid stability alters disease pathogenesis and littermate transmission. | PLoS Pathog | 2015 |